BSEBoard Meeting3 Aug 2026 · 3 Aug 2026, 02:52 pm

Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve 1.To consider and approve ....

Sandu Pharmaceuticals Ltd · 524703

✦ AI SummaryResults

Sandu Pharmaceuticals Ltd has scheduled a board meeting on 11th August 2026 to consider and approve the standalone unaudited financial results for the quarter ended 30th June 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sandu Pharmaceuticals Ltd - 524703 - Board Meeting Intimation for To Consider And Approve The Standalone Unaudited Financial Results Of The Company For The Quarter Ended 30Th June, 2026.

Attachments (1)

📄

2d9bd763-5f4e-4ad1-b062-278863688bea.pdf

pdf

Download →
View document text
%u __ SANDU PHARMACEUTICALS LIMITED CIN:L24233GA1985PLC001587 SAMDU m Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa 403511. Tel: +91 832 2407474 / 6715000, E-mail: sandupharma@sandu.in, Website: www.sandu.in Ref No: SPL/Corp.Sec/2026-27/464 Dated:03.08.2026 Department of Corporate Services Bombay Stock Exchange Limited, Phirojshah Jeejobhoy tower, Dalal Street, Mumbai-400001. Sub: Intimation about Board Meeting 29 & 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 ScripCode:524703 Respected Sir ‘We would like to inform you that a Meeting of the Board of Directors of the Company will be held on Tuesday, the 11th day of August 2026 at 04:00 p.m at the Corporate Office of the Company at Sandu Pharmaceuticals Limited, Sandu Nagar, D K Sandu Marg, Chembur, Mumbai 400 071 to consider the following 0 To consider and approve the Standalone Unaudited Financial Results of the Company for the quarter ended 30th June, 2026. O To consider any other matter with the permission of the Chair. This notice is being submitted pursuant to Regulation 29 of the Securities & Exchange Board of India (Listing Regulations and Disclosure Requirements) Regulation 2015. In Compliance with the Company’s Code of Conduct for prevention of Insider Trading devised as per the SEBI (Prohibition of Insider Trading) we would also like to inform that the trading window for dealing in the Securities of the Company has been closed for the Company’s Directors/Officer and designated employees of the Company from the opening of Trading hours on Wednesday, 01% day of July 2026 till 48 hours after announcement of financial results to public for the Quarter ended 30" June 2026 in compliances with the code of conduct for prevention of Insider Trading Regulation 2015. You are requested to kindly take note of the same. ThanKing you, Yours Faithfully, FOR SANDU PHARMACEUTICALS LIMITED. Pratika Mhambray Company Secretary & Compliance Officer A:36512 AN ISO 9001:2015 CERTIFIED ORGANISATION Corporate Office: P B. No. 17201, Sandu Nagar, D. K. Sandu Marg, Chembur, Mumbai - 400 071 Tel.: +91 22 2528 4402 / 3306, E-mail: info@sandu.in